Nivalis Therapeutics adds Cynthia Smith to board
Ms. Smith has more than 20 years of broad leadership experience within the healthcare industry.
Since 2013, Ms. Smith has served as chief commercial officer and a member of the executive team of ZS Pharma, where she led efforts to transition the company from the development stage to a commercial enterprise.
ZS Pharma was acquired by AstraZeneca in 2015.
Prior to joining ZS Pharma, Ms. Smith served as vice president, market access and commercial development at Affymax, Inc.
She also held various senior leadership positions in market access, corporate strategy, government relations and external affairs at Merck & Co.
Before beginning her career in the biopharmaceutical industry, Ms. Smith served as a healthcare policy analyst in the White House Office of Management and Budget.
Ms. Smith earned her M.B.A. from the Wharton School of the University of Pennsylvania, and a M.S. in public policy from the Eagleton Institute of Politics at Rutgers University. She received a B.A. from the University of North Carolina at Chapel Hill. ■
LATEST MOVES FROM Colorado
- DaVita appoints chief medical officer of VillageHealth
- Woodward appoints Eileen Drake to board of directors
- Woodward names Daniel Korte to board of directors
- Zayo Group appoints two executives
- ENSERVCO appoints Christopher D. Haymons to board
More inside POST